Aranesp should be administered by the subcutaneous route to patients with anaemia (e. g. haemoglobin concentration ≤ 10 g/ dl (6.2 mmol/ l)) in order to increase haemoglobin to not greater than 12 g/ dl (7.5 mmol/ l).
Aneemiaga patsientidele (nt hemoglobiini kontsentratsioon ≤ 10 g/ dl (6, 2 mmol/ l)) peab Aranesp’ i manustama subkutaanselt, et hemoglobiin tõuseks kuni tasemeni 12 g/ dl (7, 5 mmol/ l).